Weekly CEO News from Richard Ingram
October 27, 2015

Apple’s (AAPL – Analyst Report) better than expected earnings report follows strong readings from other Tech sector bellwethers like Google’s parent Alphabet (GOOGL – Analyst Report), Microsoft (MSFT – Analyst Report) and Amazon (AMZN – Analyst Report). Amazon is basically a retailer, but it’s ability to turn that space upside down has been a function

Read more

Gilead Sciences Inc (GILD – Analyst Report) is an American biopharmaceutical company that is well-known for developing and commercializing antiviral drugs that help to treat patients infected with HIV, Hepatitis B, and Hepatitis C. The company has over 19 drugs in its core

Read more

Based on the dollar volume of the deals announced this year so far, it appears that M&A activity is heading for a record year in 2015. As a long time market watcher and investor, this is a major “watch out”

Read more

The waiting game continues for Apple’s earnings given how important the company’s weighting is to many indexes. After the close of trading Apple’s (AAPL) earnings beat estimates of $1.88, and whisper estimates of $1.93, coming in at $1.96. Revenues for

Read more

Nikkei closed down almost 1% whilst the rest of Asian Equities mopped around unchanged. Not too much again to write about but people are talking about the possible BOJ action at the end of the week and still about the PBoC

Read more

FOMC Statement today Today is the FOMC Statement, and of course that will move the markets in general. Without a doubt, the US dollar will be one of the biggest movers of the day, but it also has an effect

Read more

Microsoft (MSFT) is a good Wyckoff stock as it shows accumulation and markup behaving as it should. This means when a accumulation base is followed by a mark up the larger market participants are finding favor with the fundamentals of

Read more

Nice Rally today on Biopharma Earnings: BIIB, BMY,GILD Strong Overall Biotech Tape Today, with Healthcare As Leading Sector. Biopharma and healthcare stocks firmed up today helped by Biogen (BIIB) earnings last week and today again with Gilead Sciences (GILD). Over the

Read more

Well, for whatever reasons, “investors” bid up the stock of never-earned-a-cent Twitter (TWTR) today, and now that earnings quarterly results are out, the stock is down double-digits in percentage terms (I’ve tinted the area where bid/ask is right now).   The much more important

Read more

After the closing bell Tuesday, Apple (AAPL – Analyst Report) and Twitter (TWTR – Analyst Report) posted better-than-expected quarterly earnings numbers. Apple managed to jump through just about every closely watched hoop in its fiscal Q4, with earnings per share of $1.96 and $51.5

Read more